May 12, 2021 / 06:45PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
All right. Good day, everybody. Thanks for joining us to the Bank of America Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biopharma analysts, and I'm pleased to be introducing our next company presenter, Alkermes. Joining us today is Blair Jackson, COO. And we've got Iain Brown, CFO.
Blair has got a few prepared remarks, and then we'll jump into Q&A.
)
Blair C. Jackson - Alkermes plc - Executive VP & COO
Great. Well, thank you, Jason. It's nice to be here. As a reminder to everyone, we will be making some forward-looking statements today, so I encourage everybody to review our SEC filings.
As we move through Q2 of this year, I think it's important just to level set where we are as an organization, and it's really about execution for us. There's a lot of really interesting elements of the company as we move forward.
And maybe we'll start first with the pipeline. I guess, the most proximal event that we
Alkermes Plc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot